Skip to content
OpenCapital
Get started

Relmada Therapeutics, Inc. RLMD Gross realized gains (losses)

Gross realized gains (losses) at other companies

The Travelers Companies logo
The Travelers CompaniesTRV
$49M+180%
Citizens Financial Services, Inc. logo
Citizens Financial Services, Inc.CZFS
$0—
USCB Financial Holdings, Inc. logo
USCB Financial Holdings, Inc.USCB
$82K—
Trustco Bank Corp logo
Trustco Bank CorpTRST
$0—
Employers Holdings logo
Employers HoldingsEIG
$15.48M+1,090%
American Resources Investment Trust Inc logo
American Resources Investment Trust IncINV
$0-100%

Other financials

Income statement

See full
Operating income-$19.5M-6.8%
Net income-$19.1M-8.5%
EPS (diluted)-$0.22+62.1%

Balance sheet

See full
Cash & equivalents$9.8M+750%
Total debt$104.1M-40.4%
Total equity$218.7M+875%
Total assets$235.4M+750%

Cash flow

See full
Operating cash flow-$15.1M+16.6%

Valuation

See full
Market cap$677.17M+2,907%

Returns & leverage

See full
Return on equity-48.8%-20.0pp
Debt / equity0.9×0.0×
Current ratio18.3×+13.0×

Where this comes from

Reported directly by Relmada Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RealizedInvestmentGainsLosses.

The official record: Relmada Therapeutics, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Relmada Therapeutics, Inc.'s gross realized gains (losses).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Relmada Therapeutics, Inc.'s gross realized gains (losses)?
Relmada Therapeutics, Inc. (RLMD) reported gross realized gains (losses) of -$9.87K in Q1 2026.
How has Relmada Therapeutics, Inc.'s gross realized gains (losses) changed year-over-year?
Relmada Therapeutics, Inc.'s gross realized gains (losses) decreased by 115.7% year-over-year, from $62.95K to -$9.87K.
What is the long-term trend for Relmada Therapeutics, Inc.'s gross realized gains (losses)?
Over 4 years (2021 to 2025), Relmada Therapeutics, Inc.'s gross realized gains (losses) has grown at a -40.6% compound annual growth rate (CAGR), from -$636.01K to -$79.21K.